Financing ·
Abbott Laboratories has entered into a pricing agreement to issue $20 billion in senior notes, comprising various…
ABTAbbott Laboratories
Abbott Laboratories has entered into a pricing agreement to issue $20 billion in senior notes, comprising various fixed and floating rate instruments with maturities through 2066. The company intends to use the proceeds to fund the acquisition of Exact Sciences Corporation and to repay related indebtedness. This substantial debt issuance is a critical component of Abbott's strategy to finance its major strategic expansion through the Exact Sciences deal.